- Trials with a EudraCT protocol (13)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
13 result(s) found for: Protein Kinases.
Displaying page 1 of 1.
EudraCT Number: 2005-003098-26 | Sponsor Protocol Number: 3144A1-201-WW | Start Date*: 2006-06-06 |
Sponsor Name:Wyeth Research Division of Wyeth Pharmaceuticals Inc. | ||
Full Title: Phase 2 Study of HKI-272 in Subjects with Advanced Breast Cancer | ||
Medical condition: Breast cancer is the most frequently diagnosed malignancy and the second most common cause of cancer related deaths in women. HER2 is a member of the epidermal growth factor receptor (EGFR) family ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: BE (Completed) FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-002834-35 | Sponsor Protocol Number: PARERE | Start Date*: 2020-09-24 | |||||||||||
Sponsor Name:G.O.N.O. - GRUPPO ONCOLOGICO DEL NORD OVEST | |||||||||||||
Full Title: Randomized phase II study of PAnitumumab REchallenge followed by REgorafenib versus the reverse sequence in RAS and BRAF WILD-TYPE chemorefractory metastatic colorectal cancer patients. | |||||||||||||
Medical condition: RAS and BRAF wild-type chemorefractory metastatic colorectal cancer patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002655-14 | Sponsor Protocol Number: 29BRC18.0144 | Start Date*: 2019-09-05 | |||||||||||
Sponsor Name:CHRU BREST | |||||||||||||
Full Title: BAriCitinib Healing Effect in earLy pOlymyalgia Rheumatica (BACHELOR study) | |||||||||||||
Medical condition: polymyalgia rheumatica | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004017-17 | Sponsor Protocol Number: RR11/9965 | Start Date*: 2013-04-08 |
Sponsor Name:The University of Leeds | ||
Full Title: Prospective, Single-centre, Open-Label, Randomised, Pilot Study Assessing the changes in expression of JAK-STAT and Speed & Depth of Remission Induced by Tocilizumab & Methotrexate Combination and ... | ||
Medical condition: Rheumatoid Arthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-004031-31 | Sponsor Protocol Number: RVH006 | Start Date*: 2011-11-15 | |||||||||||
Sponsor Name:RespiVert Ltd | |||||||||||||
Full Title: A randomised, double-blind, placebo-controlled, parallel group study to evaluate the safety and tolerability of treatment with repeat doses of inhaled RV568 in patients with COPD. | |||||||||||||
Medical condition: chronic obstructive pulmonary disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-013279-23 | Sponsor Protocol Number: NCT-2008-11-02-1020 | Start Date*: 2010-03-04 | |||||||||||
Sponsor Name:University Hospital of Heidelberg | |||||||||||||
Full Title: In vivo response monitoring of treatment with the EGFR-monoclonal-antibody Cetuximab in metastatic colorectal cancer – a single center phase II study | |||||||||||||
Medical condition: metastatic colorectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001238-32 | Sponsor Protocol Number: ADVL1622 | Start Date*: 2019-09-26 |
Sponsor Name:National Cancer Institute Cancer Therapy Evaluation | ||
Full Title: Phase 2 Trial of XL184 (Cabozantinib) an Oral Small-Molecule Inhibitor of Multiple Kinases, in Children and Young Adults with Refractory Sarcomas, Wilms Tumor, and Other Rare Tumors | ||
Medical condition: Ewing sarcoma, Rhabdomyosarcoma, Non rhabdomyosarcoma, Wilms Tumor, Osteosarcoma and Other Rare Tumors | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2015-005572-17 | Sponsor Protocol Number: 15775407 | Start Date*: 2016-02-22 | |||||||||||
Sponsor Name:CHU TOULOUSE | |||||||||||||
Full Title: Assessment in real life of the association and its determinants between adverse events, and plasma concentrations of two protein kinases inhibitors: Ibrutinib (IMBRUVICA®) and idelalisib (ZYDELIG®)... | |||||||||||||
Medical condition: Hematological malignancies | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001184-11 | Sponsor Protocol Number: VIAject-15J | Start Date*: 2008-04-22 | |||||||||||
Sponsor Name:Biodel Inc | |||||||||||||
Full Title: Effect of prandial treatment with insulin VIAjectTM compared to regular human insulin and insulin lispro on postprandial endothelial function and microvascular stress in type 2 diabetic patients | |||||||||||||
Medical condition: Type 2 Diabetes Mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002555-10 | Sponsor Protocol Number: DS1062-A-U304 | Start Date*: 2022-05-05 | |||||||||||
Sponsor Name:Daiichi Sankyo, Inc. | |||||||||||||
Full Title: A Randomized, Open-label, Phase 3 Trial of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in Treatment-naïve Subjects with Advanced or Metastatic PD-L1 High (TPS ≥50%) Non-small Cell Lung Cance... | |||||||||||||
Medical condition: Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) IT (Ongoing) DE (Trial now transitioned) NL (Ongoing) GR (Ongoing) PT (Trial now transitioned) HU (Ongoing) PL (Trial now transitioned) AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000364-15 | Sponsor Protocol Number: SUNRISE-CRC | Start Date*: 2019-09-11 |
Sponsor Name:VU University Medical Center, Department of Medical | ||
Full Title: A randomized phase II/III study of pulsatile high-dose sunitinib versus TAS-102 in patients with metastatic colorectal carcinoma (mCRC). | ||
Medical condition: Advanced colorectal tumors | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2010-022113-25 | Sponsor Protocol Number: RVH002 | Start Date*: 2010-10-20 | |||||||||||
Sponsor Name:RespiVert Ltd | |||||||||||||
Full Title: A two day, randomised, single blind, parallel group trial of repeat doses of intranasal RV568 in the Vienna Challenge Chamber in subjects with seasonal allergic rhinitis (SAR) | |||||||||||||
Medical condition: Seasonal Allergic Rhinitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002155-17 | Sponsor Protocol Number: LAP105594 | Start Date*: 2008-04-18 | |||||||||||
Sponsor Name:GlaxoSmithKline Research and Development Limited | |||||||||||||
Full Title: A phase II open label, multicenter study to evaluate the efficacy and safety of daily dose of Lapatinib in advanced breast cancer patients with HER-2 non-amplified primary tumours and HER-2 positiv... | |||||||||||||
Medical condition: Advanced breast cancer patients with HER-2 non-amplified primary tumours and HER-2 positive circulating tumour cells or EGFR positive circulating tumour cells | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.